Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Lyra Therapeutics, Inc. (LYRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4/A Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 150,000 options @ $2.99, valued at $448.5k
07/05/2023 4 TOBIN JAMES R (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
07/05/2023 4 Smith W Bradford (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
07/05/2023 4 Poukalov Konstantin (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
07/05/2023 4 ALTMAN MICHAEL SETH (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
07/05/2023 4 MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
07/05/2023 4 ANDERSON EDWARD T (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
07/05/2023 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
02/28/2023 4 Bishop John E (Chief Technology Officer) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 220,000 options @ $2.31, valued at $508.2k
02/28/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 200,000 options @ $2.85, valued at $570k
02/02/2023 4 Noyes Corinne (See Remarks) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 36,667 shares @ $0
Granted 55,000 options @ $2.85, valued at $156.8k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 250,000 options @ $2.85, valued at $712.5k
02/02/2023 4 Nieman Richard (Chief Medical Officer) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 55,537 options @ $2.85, valued at $158.3k
07/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/21/2022 4 MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 7,250 options @ $5.09, valued at $36.9k
06/21/2022 4 ALTMAN MICHAEL SETH (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 7,250 options @ $5.09, valued at $36.9k
06/21/2022 4 Smith W Bradford (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 7,250 options @ $5.09, valued at $36.9k
06/21/2022 4 Poukalov Konstantin (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 7,250 options @ $5.09, valued at $36.9k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 7,250 options @ $5.09, valued at $36.9k
06/13/2022 4 MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 4,000 shares @ $5.05, valued at $20.2k
05/17/2022 4 MERRIFIELD C ANN (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 3,500 shares @ $4.813, valued at $16.8k
Bought 328 shares @ $5, valued at $1.6k
04/14/2022 4 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 5,924,170 shares @ $4.22, valued at $25M
04/14/2022 4 NBVM GP, LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 1,076,851 shares @ $4.22, valued at $4.5M
Bought 527,806 shares @ $4.22, valued at $2.2M
Bought 765,010 shares @ $4.22, valued at $3.2M
04/14/2022 4 ANDERSON EDWARD T (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 1,076,851 shares @ $4.22, valued at $4.5M
Bought 527,806 shares @ $4.22, valued at $2.2M
Bought 765,010 shares @ $4.22, valued at $3.2M
Bought 118,483 shares @ $4.22, valued at $500k
04/13/2022 4 Waksal Harlan (Executive Chair) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 236,966 shares @ $4.22, valued at $1000k
03/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
02/18/2022 4 Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 175,000 options @ $4.21, valued at $736.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy